Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEDI:LX

116.36 EUR 1.93 1.63%

As of 00:59:30 ET on 04/17/2015.

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEDI)

Year To Date: +22.01% 3-Month: +15.54% 3-Year: +33.96% 52-Week Range: 70.77 - 120.08
1-Month: -0.64% 1-Year: +67.98% 5-Year: +22.35% Beta vs LUXXX: 0.68

Mutual Fund Chart for CARMEDI

No chart data available.
  • CARMEDI:LX 116.36
  • 1M
  • 1Y
Interactive CARMEDI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARMEDI

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-1998 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegie.se

Fundamentals for CARMEDI

NAV (on 2015-04-17) 116.36
Assets (M) (on 2015-03-31) 760.66
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CARMEDI

No dividends reported

Fees & Expenses for CARMEDI

Front Load -
Back Load -
Current Mgmt Fee 1.70
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEDI

Filing Date: 03/31/2015
Name Position Value % of Total
Gilead Sciences Inc 529,672 48,979,732 6.439%
UnitedHealth Group Inc 351,158 39,284,022 5.164%
Johnson & Johnson 413,186 38,901,002 5.114%
Novartis AG 410,862 37,987,432 4.994%
Amgen Inc 228,638 34,490,616 4.534%
Pfizer Inc 1,036,315 33,629,788 4.421%
Roche Holding AG 128,741 33,146,372 4.358%
Carnegie Fund V - The Carnegie 85,642 32,325,472 4.250%
Celgene Corp 283,838 31,057,373 4.083%
Biogen Inc 75,892 30,281,848 3.981%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil